Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
229.19
-2.85 (-1.23%)
At close: Jun 9, 2026, 4:00 PM EDT
226.00
-3.19 (-1.39%)
After-hours: Jun 9, 2026, 7:38 PM EDT
Jazz Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, Jazz Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $253.21. The average 1-year stock price forecast is 10.48% higher than the current stock price, while the lowest is $196 (-14.48%) and the highest is $307 (+33.95%).
Price Target: $253.21 (+10.48%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Jazz Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 9 | 9 | 9 | 10 |
| Buy | 4 | 5 | 5 | 5 | 6 | 7 |
| Hold | 2 | 1 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 16 | 16 | 17 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Reiterates $234 → $253 | Buy | Reiterates | $234 → $253 | +10.39% | May 27, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $232 → $301 | Buy | Reiterates | $232 → $301 | +31.33% | May 22, 2026 |
Unknown Analyst Bernstein No rating | Bernstein | Hold Initiates $229 | Hold | Initiates | $229 | -0.08% | May 21, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains $265 | Buy | Maintains | $265 | +15.62% | May 20, 2026 |
| UBS | UBS | Buy Upgrades $188 → $307 | Buy | Upgrades | $188 → $307 | +33.95% | May 19, 2026 |
Financial Forecast
Revenue This Year
4.50B
from 4.27B
Increased by 5.46%
Revenue Next Year
4.85B
from 4.50B
Increased by 7.73%
EPS This Year
25.23
from 8.38
Increased by 201.09%
EPS Next Year
25.73
from 25.23
Increased by 1.98%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.6B | ||
| Avg | 4.5B | ||
| Low | 4.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.5% | ||
| Avg | 5.5% | ||
| Low | 3.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 26.99 | ||
| Avg | 25.23 | ||
| Low | 24.38 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 222.0% | ||
| Avg | 201.1% | ||
| Low | 190.9% |